Clinical Trials
3 trialsNCT02983045 2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2 Completed
NCT00415168 2010-08-17
Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer
Eli Lilly and Company
Phase 2 Completed
NCT00320515 2009-09-28
Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer
Eli Lilly and Company
Phase 1/2 Completed